|

CTX112 Clinical Trials

2 actively recruiting trials across 2 locations

Pipeline

Phase 1: 1Phase 1/2: 1

Top Sponsors

  • CRISPR Therapeutics AG1
  • CRISPR Therapeutics1

Indications

  • Inflammatory Myopathy, Idiopathic1
  • Myositis1
  • Diffuse Cutaneous Systemic Sclerosis1
  • SLE (Systemic Lupus)1
  • Systemic Sclerosis1

Redwood City, California1 trial

A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

Research Site 4

Phase 1

Westwood, Kansas1 trial

A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies

University of Kansas

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.